Health Net
Farydak (panobinostat)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Multiple Myeloma:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Anti-Cancer:Maximum $200 copayment per State Law. Must use AcariaHealth Specialty Rx.
  • Multiple Myeloma:
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Hematologist;Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Drug Policy Based On: 1 of FDA Approved Indications;NCCN Guidelines
    ECOG Score Requirement in Policy: N/A
    ECOG status <=2: No
    Diagnosis Types: 2 of in combination with bortezomib and dexamethasone for the treatment of multiple myeloma after at least 2 prior regimens, including bortezomib and an immunomodulatory agent;Multiple Myeloma
    Concomitant Therapy Requirement: in combination with bortezomib and dexamethasone